These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22195562)

  • 1. Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors.
    Dong CK; Urgaonkar S; Cortese JF; Gamo FJ; Garcia-Bustos JF; Lafuente MJ; Patel V; Ross L; Coleman BI; Derbyshire ER; Clish CB; Serrano AE; Cromwell M; Barker RH; Dvorin JD; Duraisingh MT; Wirth DF; Clardy J; Mazitschek R
    Chem Biol; 2011 Dec; 18(12):1602-10. PubMed ID: 22195562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex.
    Siregar JE; Kurisu G; Kobayashi T; Matsuzaki M; Sakamoto K; Mi-ichi F; Watanabe Y; Hirai M; Matsuoka H; Syafruddin D; Marzuki S; Kita K
    Parasitol Int; 2015 Jun; 64(3):295-300. PubMed ID: 25264100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A drug-selected Plasmodium falciparum lacking the need for conventional electron transport.
    Smilkstein MJ; Forquer I; Kanazawa A; Kelly JX; Winter RW; Hinrichs DJ; Kramer DM; Riscoe MK
    Mol Biochem Parasitol; 2008 May; 159(1):64-8. PubMed ID: 18308406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
    Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
    Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
    Skinner-Adams TS; Fisher GM; Riches AG; Hutt OE; Jarvis KE; Wilson T; von Itzstein M; Chopra P; Antonova-Koch Y; Meister S; Winzeler EA; Clarke M; Fidock DA; Burrows JN; Ryan JH; Andrews KT
    Commun Biol; 2019; 2():166. PubMed ID: 31069275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex.
    Biagini GA; Fisher N; Berry N; Stocks PA; Meunier B; Williams DP; Bonar-Law R; Bray PG; Owen A; O'Neill PM; Ward SA
    Mol Pharmacol; 2008 May; 73(5):1347-55. PubMed ID: 18319379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
    Stickles AM; Smilkstein MJ; Morrisey JM; Li Y; Forquer IP; Kelly JX; Pou S; Winter RW; Nilsen A; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4853-9. PubMed ID: 27270285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum.
    Stickles AM; de Almeida MJ; Morrisey JM; Sheridan KA; Forquer IP; Nilsen A; Winter RW; Burrows JN; Fidock DA; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1977-82. PubMed ID: 25605352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstructing the Qo site of Plasmodium falciparum bc 1 complex in the yeast enzyme.
    Vallières C; Fisher N; Meunier B
    PLoS One; 2013; 8(8):e71726. PubMed ID: 23951230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting Plasmodium cytochrome bc1: a complex issue.
    Barton V; Fisher N; Biagini GA; Ward SA; O'Neill PM
    Curr Opin Chem Biol; 2010 Aug; 14(4):440-6. PubMed ID: 20570550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
    Basco LK
    Am J Trop Med Hyg; 2003 Aug; 69(2):179-83. PubMed ID: 14506774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDQ, a potent inhibitor of Plasmodium falciparum proliferation, binds to the quinone reduction site of the cytochrome bc1 complex.
    Vallières C; Fisher N; Antoine T; Al-Helal M; Stocks P; Berry NG; Lawrenson AS; Ward SA; O'Neill PM; Biagini GA; Meunier B
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3739-47. PubMed ID: 22547613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antimalarial activity of new atovaquone derivatives.
    El Hage S; Ane M; Stigliani JL; Marjorie M; Vial H; Baziard-Mouysset G; Payard M
    Eur J Med Chem; 2009 Nov; 44(11):4778-82. PubMed ID: 19747753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression.
    Fisher N; Abd Majid R; Antoine T; Al-Helal M; Warman AJ; Johnson DJ; Lawrenson AS; Ranson H; O'Neill PM; Ward SA; Biagini GA
    J Biol Chem; 2012 Mar; 287(13):9731-9741. PubMed ID: 22282497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action.
    Birth D; Kao WC; Hunte C
    Nat Commun; 2014 Jun; 5():4029. PubMed ID: 24893593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites.
    Ouji M; Nguyen M; Mustière R; Jimenez T; Augereau JM; Benoit-Vical F; Deraeve C
    Bioorg Med Chem Lett; 2021 May; 39():127884. PubMed ID: 33636304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80).
    Fry M; Pudney M
    Biochem Pharmacol; 1992 Apr; 43(7):1545-53. PubMed ID: 1314606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new antimalarial leads by use of virtual screening against cytochrome bc₁.
    Rodrigues T; Moreira R; Gut J; Rosenthal PJ; O Neill PM; Biagini GA; Lopes F; dos Santos DJ; Guedes RC
    Bioorg Med Chem; 2011 Nov; 19(21):6302-8. PubMed ID: 21958736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccharomyces cerevisiae-based mutational analysis of the bc1 complex Qo site residue 279 to study the trade-off between atovaquone resistance and function.
    Song Z; Clain J; Iorga BI; Yi Z; Fisher N; Meunier B
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4053-8. PubMed ID: 25918152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi.
    Kessl JJ; Meshnick SR; Trumpower BL
    Trends Parasitol; 2007 Oct; 23(10):494-501. PubMed ID: 17826334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.